Clinical Trial Update: An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the long-term safety of magnesium iron hydroxycarbonate in chronic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Magnesium iron hydroxycarbonate (magnesium iron hydroxycarbonate)

Snippet

Sponsor: Ineos Healthcare Limited | Conditions: Chronic Kidney Failure | Phase 2 | Status: TERMINATED